116 related articles for article (PubMed ID: 8738058)
1. Effects of androgen therapy on prostatic markers in hemodialyzed patients.
Teruel JL; Aguilera A; Avila C; Ortuño J
Scand J Urol Nephrol; 1996 Apr; 30(2):129-31. PubMed ID: 8738058
[TBL] [Abstract][Full Text] [Related]
2. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients.
Gaughan WJ; Liss KA; Dunn SR; Mangold AM; Buhsmer JP; Michael B; Burke JF
Am J Kidney Dis; 1997 Oct; 30(4):495-500. PubMed ID: 9328363
[TBL] [Abstract][Full Text] [Related]
3. Androgen therapy for anaemia of chronic renal failure. Indications in the erythropoietin era.
Teruel JL; Aguilera A; Marcen R; Navarro Antolin J; Garcia Otero G; Ortuño J
Scand J Urol Nephrol; 1996 Oct; 30(5):403-8. PubMed ID: 8936631
[TBL] [Abstract][Full Text] [Related]
4. The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients.
Barton Pai A; Chretien C; Lau AH
Clin Nephrol; 2002 Jul; 58(1):38-46. PubMed ID: 12141405
[TBL] [Abstract][Full Text] [Related]
5. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease.
Ballal SH; Domoto DT; Polack DC; Marciulonis P; Martin KJ
Am J Kidney Dis; 1991 Jan; 17(1):29-33. PubMed ID: 1986567
[TBL] [Abstract][Full Text] [Related]
6. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
Navarro JF; Mora C; Macía M; García J
Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
[TBL] [Abstract][Full Text] [Related]
7. Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients.
Teruel JL; Lasuncion MA; Rivera M; Aguilera A; Ortega H; Tato A; Marcen R; Ortuño J
Am J Kidney Dis; 1997 Apr; 29(4):569-75. PubMed ID: 9100047
[TBL] [Abstract][Full Text] [Related]
8. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Johansen KL; Mulligan K; Schambelan M
JAMA; 1999 Apr; 281(14):1275-81. PubMed ID: 10208142
[TBL] [Abstract][Full Text] [Related]
9. Effects of adjuvant androgen on anemia and nutritional parameters in chronic hemodialysis patients using low-dose recombinant human erythropoietin.
Lee MS; Ahn SH; Song JH
Korean J Intern Med; 2002 Sep; 17(3):167-73. PubMed ID: 12298427
[TBL] [Abstract][Full Text] [Related]
10. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
[TBL] [Abstract][Full Text] [Related]
11. Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study.
Teruel JL; Marcén R; Navarro JF; Villafruela JJ; Fernández Lucas M; Liaño F; Ortuño J
Nephron; 1995; 70(3):282-6. PubMed ID: 7477614
[TBL] [Abstract][Full Text] [Related]
12. Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients.
Mora C; Macía ML; García J; Navarro JF
Perit Dial Int; 2001; 21(6):611-4. PubMed ID: 11783772
[No Abstract] [Full Text] [Related]
13. Androgens for the treatment of anemia in peritoneal dialysis patients.
Navarro JF; Mora-Fernández C; Rivero A; Macía M; Gallego E; Chahin J; Méndez ML; García J
Adv Perit Dial; 1998; 14():232-5. PubMed ID: 10649731
[TBL] [Abstract][Full Text] [Related]
14. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study.
Teruel JL; Marcen R; Navarro-Antolin J; Aguilera A; Fernandez-Juarez G; Ortuño J
J Am Soc Nephrol; 1996 Jan; 7(1):140-4. PubMed ID: 8808121
[TBL] [Abstract][Full Text] [Related]
15. Nutritional effect of nandrolone decanoate in predialysis patients with chronic kidney disease.
Eiam-Ong S; Buranaosot S; Eiam-Ong S; Wathanavaha A; Pansin P
J Ren Nutr; 2007 May; 17(3):173-8. PubMed ID: 17462549
[TBL] [Abstract][Full Text] [Related]
16. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys.
Jerome CP; Power RA; Obasanjo IO; Register TC; Guidry M; Carlson CS; Weaver DS
Bone; 1997 Apr; 20(4):355-64. PubMed ID: 9108356
[TBL] [Abstract][Full Text] [Related]
17. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
Berns JS; Rudnick MR; Cohen RM
Clin Nephrol; 1992 May; 37(5):264-7. PubMed ID: 1606777
[TBL] [Abstract][Full Text] [Related]
18. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
Chlebowski RT; Herrold J; Ali I; Oktay E; Chlebowski JS; Ponce AT; Heber D; Block JB
Cancer; 1986 Jul; 58(1):183-6. PubMed ID: 3518910
[TBL] [Abstract][Full Text] [Related]
19. Nandrolone decanoate therapy for anemia in patients on haemodialysis.
Balaji HD; Hariharan S; Jacob CK; Kirubakaran MG; Shastry JC
J Assoc Physicians India; 1988 Nov; 36(11):677-8. PubMed ID: 3074079
[No Abstract] [Full Text] [Related]
20. Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis.
Gascón A; Belvis JJ; Berisa F; Iglesias E; Estopiñán V; Teruel JL
Geriatr Nephrol Urol; 1999; 9(2):67-72. PubMed ID: 10518249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
